4
Changes in Ownership
Taysha Gene Therapies, Inc. Filed Acc 0001209191-21-052824
Chief Financial Officer sold 33,000 shares at an average $16.88 ($557,023)
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X03/doc4.xml…